Molecular evolution of human influenza H3N2 virus hemagglutinin genes in Guangdong China.
- Author:
Ping HUANG
1
;
Jing ZHONG
;
Li-Jun LIANG
;
Nian-Mei HOU
;
Han-Zhong NI
;
Jie WU
;
Xin ZHANG
Author Information
1. Key Laboratory for Emergency Pathogen Detection, Guangdong Provincial Center for Disease Control and Prevention, Guangzhou 510300, China. pphuang1@163.com
- Publication Type:Journal Article
- MeSH:
Amino Acid Substitution;
China;
Disulfides;
chemistry;
Epitopes;
genetics;
Evolution, Molecular;
Hemagglutinin Glycoproteins, Influenza Virus;
chemistry;
genetics;
immunology;
Humans;
Influenza A Virus, H3N2 Subtype;
genetics;
Mutation;
Phylogeny
- From:
Chinese Journal of Virology
2012;28(4):330-335
- CountryChina
- Language:Chinese
-
Abstract:
The molecular characterization and phylogenetic analysis of hemagglutinin (HA) genes of human influenza H3N2 viruses in Guangdong, China from 2007 to 2010 were studied in this study. By space-time sampling of strains, the HA genes of H3N2 strains from Guangdong were sequenced and searched from Internet, and then the variation and evolution of HA genes were conducted by Lasergene 7.1 and Mega 5.05 and evolutionary rates were analyzed by epidemiological data. The phylogenetic tree was established by alignment of 17 Guangdong strains and 26 global reference strains. Ks rates and Ka rates of HA genes were 2.06 x 10(-3)-2.23 x 10(-3) Nt/Year and 1.05 x 10(-3)-1.21 x 10(3) Nt/Year during 2007-2010, while the velocity of HA1 evolution of Ka was 3. 13 times than that of HA2 evolution. Compared with HA of vaccine strain A/Perth/16/2009, the genetic homologies of Guangdong strains in 2009 reached to 98.8%-99.7% and of Guangdong strains in 2010 reached to 98.0%-98.4%. There were some amino acid substitutions in five epitope regions of HA1 during 2007-2010, especially in B region (N160K) and D region (K174R/N); the K189E/N/Q and T228A in RBS (receptor-binding site) occurred in 2010 as two glycoproteins sites substituted impacted on the HA1 antigenicity. The antigenicity of epidemic H3N2 strains in 2010 was to some degree different that of the vaccine strain A/ Perth/16/2009. According to that there were variations of B and D epitopes and two sites of RBS and two glycoprotein in Guangdong H3N2 HA1 genes, WHO/ CDC should recommend new representative strains during 2011-2012 influenza seasons if H3N2 HA genes further evolve in the near future.
